230 related articles for article (PubMed ID: 31921679)
1. Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.
Frandsen S; Broholm H; Larsen VA; Grunnet K; Møller S; Poulsen HS; Michaelsen SR
Front Oncol; 2019; 9():1425. PubMed ID: 31921679
[No Abstract] [Full Text] [Related]
2. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database.
Frandsen J; Orton A; Jensen R; Colman H; Cohen AL; Tward J; Shrieve DC; Suneja G
J Neurosurg; 2018 Apr; 128(4):1133-1138. PubMed ID: 28621623
[TBL] [Abstract][Full Text] [Related]
3. Gliosarcoma: an audit from a single institution in India of 24 post-irradiated cases over 15 years.
Kumar P; Singh S; Kumar P; Krishnani N; Datta NR
J Cancer Res Ther; 2008; 4(4):164-8. PubMed ID: 19052388
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
5. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
7. Clinical and survival characteristics of primary and secondary gliosarcoma patients.
Amer A; Khose S; Alhasan H; Pokhylevych H; Fuller G; Chasen N; de Groot J; Johnson JM
Clin Neurol Neurosurg; 2022 Mar; 214():107146. PubMed ID: 35101778
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
[TBL] [Abstract][Full Text] [Related]
9. Primary Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma? An Update of the Clinical, Radiological, and Biomolecular Characteristics.
La Torre D; Della Torre A; Lo Turco E; Longo P; Pugliese D; Lacroce P; Raudino G; Romano A; Lavano A; Tomasello F
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202090
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.
Costa BM; Caeiro C; Guimarães I; Martinho O; Jaraquemada T; Augusto I; Castro L; Osório L; Linhares P; Honavar M; Resende M; Braga F; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires M; Pinheiro C; Carvalho E; Lopes JM; Costa P; Damasceno M; Reis RM
Oncol Rep; 2010 Jun; 23(6):1655-62. PubMed ID: 20428822
[TBL] [Abstract][Full Text] [Related]
11. Gliosarcoma: a clinical study.
Lutterbach J; Guttenberger R; Pagenstecher A
Radiother Oncol; 2001 Oct; 61(1):57-64. PubMed ID: 11578729
[TBL] [Abstract][Full Text] [Related]
12. Primary versus secondary gliosarcoma: a systematic review and meta-analysis.
Vuong HG; Dunn IF
J Neurooncol; 2022 Aug; 159(1):195-200. PubMed ID: 35768633
[TBL] [Abstract][Full Text] [Related]
13. Cerebral gliosarcoma: Analysis of 16 patients and review of literature.
Singh G; Das KK; Sharma P; Guruprasad B; Jaiswal S; Mehrotra A; Srivastava AK; Sahu RN; Jaiswal AK; Behari S
Asian J Neurosurg; 2015; 10(3):195-202. PubMed ID: 26396606
[TBL] [Abstract][Full Text] [Related]
14. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
Younis SG; Khedr RA; El-Shorbagy SH
J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
[TBL] [Abstract][Full Text] [Related]
18. Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcoma.
Dejonckheere CS; Böhner AMC; Koch D; Schmeel LC; Herrlinger U; Vatter H; Schneider M; Schuss P; Giordano FA; Köksal MA
Strahlenther Onkol; 2022 May; 198(5):468-474. PubMed ID: 34939129
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.
Jin MC; Liu EK; Shi S; Gibbs IC; Thomas R; Recht L; Soltys SG; Pollom EL; Chang SD; Hayden Gephart M; Nagpal S; Li G
Front Oncol; 2020; 10():337. PubMed ID: 32219069
[No Abstract] [Full Text] [Related]
20. Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database.
Shieh LT; Ho CH; Guo HR; Huang CC; Ho YC; Ho SY
Front Neurol; 2021; 12():659921. PubMed ID: 34899553
[No Abstract] [Full Text] [Related]
[Next] [New Search]